MobiHealthNews

FDA approves Dexcom for Bluetooth-enabled CGM G5

The FDA has approved San Diego, California-based Dexcom for a Bluetooth-enabled continuous glucose monitor (CGM), called the G5 Mobile CGM system. Correction: A previous version of this article ...
Medscape

FDA Okays Use of Dexcom G5 CGM for Insulin Dosing

For the first time, the US Food and Drug Administration has approved the use of a continuous glucose monitoring (CGM) system to replace finger-stick testing for determining insulin doses. The decision ...
Business Wire

Tandem Diabetes Care Announces FDA Approval and Launch of t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM Integration

Dexcom is also consistently rated the #1 CGM brand in independent patient surveys 5. In addition to integration with the t:slim X2 Pump, dynamic glucose data from the Dexcom G5 Mobile CGM can be ...
FierceBiotech

FDA panel gives Dexcom’s G5 continuous glucose monitor favorable vote

As expected, an FDA panel voted in favor of giving Dexcom’s ($DXCM) G5 continuous glucose monitor a nonadjunctive indication that would allow it to be used in place ...
Seeking Alpha

FDA OKs expanded use for DexCom's G5 glucose monitoring system; shares up 3%

The FDA has signed off on the use of DexCom's (NASDAQ:DXCM +2.9%) G5 Continuous Glucose Monitoring System to make diabetes treatment decisions in patients at least two years old without the need for a ...
Business Wire

Tandem Diabetes Care Announces FDA Approval and Launch of t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM Integration

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced ...